Newest
FIP ▲ bought $1.5M · Nicholson Kenneth J. filed 1d agoHUM ▼ sold $2.4M · Ventura Joseph C filed 1d agoWEC ▼ sold $2.2M · KELSEY MARGARET C filed 1d agoLH ▼ sold $744K · Caveney Brian J filed 1d agoDOX ▲ bought $6K · MORALI VERONIQUE filed 1d agoDOX ▲ bought $37K · MacDonald John Anthony filed 1d agoDOX ▲ bought $4K · MacDonald John Anthony filed 1d agoDOX ▲ bought $35K · Davis Sarah R. filed 1d agoDOX ▲ bought $150K · Genish Amos filed 1d agoDOX ▲ bought $101K · Kanouff Yvette filed 1d agoFERG ▼ sold $238K · Winckler Richard filed 1d agoFERG ▼ sold $595K · Paisley James A. filed 1d agoTDY ▼ sold $141K · Belak Cynthia Y filed 1d agoTDY ▼ sold $2.8M · Belak Cynthia Y filed 1d agoEBAY ▼ sold $1.2M · Loeger Julie A filed 1d agoEBAY ▼ sold $3.9M · Loeger Julie A filed 1d agoCOHR ▲ bought $223K · Digirolomo Enrico filed 1d agoCOHR ▲ bought $997K · ANDERSON JAMES ROBERT filed 1d ago

Insider / AMGEN INC

Drake Michael V

Director at AMGEN INC

Company
AMGEN INC
Ticker
AMGN
First filing on record
November 12, 2025
Latest trade on record
November 6, 2026
SEC filings
EDGAR ↗

Drake Michael V, Director at AMGEN INC, has disclosed 5 transactions in AMGN since November 12, 2025: 0 purchases (0 open-market buys) and 0 sales, worth about $0 at the reported prices. The latest was filed November 9, 2026, 3 days after the trade; 1 filing was late against the 2-business-day Form 4 deadline.

Last updated November 9, 2026 · Source: SEC EDGAR Form 4 filings

Transactions
5
Open-market buys
0
Sales
0
Avg. disclosure lag
3.0d

Trading in charts

Trade timeline

When does this person trade, how big, and in which direction? Every trade in the last 12 months.

Bought (above the line)Sold (below the line)Other transaction
Nov 25DecJan 26FebMarAprMayJunJulAugSepOct
Nov 25DecJan 26FebMarAprMayJunJulAugSepOct

In the last 12 months Drake Michael V reported 4 transactions that were neither a purchase nor a sale, such as stock awards, option exercises or shares withheld for tax.

Reporting lag

Does this person report on time? One bar per filing against the Form 4 deadline.

On timeLate
Form 4 deadlineoldest filingnewest

1 of 5 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).

What kind of transactions

Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.

Rows by Form 4 transaction code
CodeMeaningRowsSharesValue
AGrant or award51,141—
Rows by year of the trade
YearRowsBoughtSold
2026400
2025100

Transactions

Download AMGN trades (CSV)169 rows · 55 KB · every filer in this ticker, this insider included · all downloads

SecuritySideTrade dateDisclosedLagSharesPriceValueFlagsSourceShare
AMGNOther ANovember 6, 2026November 9, 20263d114——Form 4 ↗
AMGNOther AAugust 7, 2026August 10, 20263d64——Form 4 ↗
AMGNOther AMay 19, 2026May 21, 20262d665——Form 4 ↗
AMGNOther AMay 5, 2026May 7, 20262d80——Form 4 ↗
AMGNOther ANovember 7, 2025November 12, 20255d219——lateForm 4 ↗

Filings

FiledFormAccessionRowsStatusSource
November 9, 2026Form 40000318154-26-0001601publishedEDGAR ↗
August 10, 2026Form 40000318154-26-0001311publishedEDGAR ↗
May 21, 2026Form 40000318154-26-0000991publishedEDGAR ↗
May 7, 2026Form 40000318154-26-0000691publishedEDGAR ↗
November 12, 2025Form 40000318154-25-0000771publishedEDGAR ↗

Other insiders at AMGEN INC

Everyone on file, with contracts and lobbying under the company's name: AMGEN INC.

Guides for this page

Sources and method

Official sources behind this page
SourceFilingsRowsFirst filedNewest filedRead the originals
SEC EDGAR, Form 455November 12, 2025November 9, 2026Form 4 list on EDGAR

Site built November 12, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.

Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.

Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.